Maria Fawaz
Associate Principal Scientist Merck & Co
Seminars
Thursday 30th April 2026
Peptide Inhibitor of Pan Corona Virus Fusion Protein
3:15 pm
- Introducing of the Pan-Cov peptide inhibitor program and showcasing the peptide modality strategy
- Establishing in vitro and ex vivo efficacy assays for peptide optimization
- Discussing the challenges associated with peptide PK and biodistribution
NEW DATA
Wednesday 29th April 2026
Fireside Peptide Delivery Discussion – Pushing the Limits of Peptide Formulation & Delivery from Novel Design to Effective Targeting Strategies for Better Patient Outcomes
3:30 pm
- How to effectively design patient-centric peptide delivery formulations (oral vs injectable)?
- How to ensure novel peptide formulations can be scalable and cost efficient during the manufacturing process?
- Where will delivery innovations take the peptide field in the next 5 years?
